Recherche
-
Genome-Wide Investigation of Exogenous Female Hormones, Genetic Variation, and Venous Thromboembolism Risk
(Journal of Thrombosis and Haemostasis, 2024-05-21)Article de revue -
Three-dimensional cardiac magnetic resonance allows the identification of slow-conducting anatomical isthmuses in tetralogy of Fallot
(European Heart Journal. vol. 45, n° 23, pp. 2079-2094, 2024-05-14)Article de revue -
Short-term Darolutamide (ODM-201) Concomitant to Radiation Therapy for Patients with Unfavorable Intermediate-risk Prostate Cancer: The Darius (AFU-GETUG P15) Phase 2 Trial Protocol
(European Urology Oncology, 2024-05-15)Article de revue -
Quality of life in retired workers with past exposure to asbestos
(American Journal of Industrial Medicine. vol. 67, n° 7, pp. 610-623, 2024-07-01)Article de revueLibre accès -
The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impact
(Alzheimer's & Dementia : the Journal of the Alzheimer's Association. vol. 20, n° 6, pp. 4290-4314, 2024-06-01)Article de revueLibre accès -
A mixed-methods project on the impact of the mental health first aid training on French university students' knowledge, attitudes and practices
(Early intervention in psychiatry. vol. 18, n° 5, pp. 366-373, 2024-05-01)Article de revue -
Increased risk of renal events in people with diabetic foot disease: A longitudinal observational study
(Diabetes & Metabolism. vol. 50, n° 4, pp. 101536, 2024-05-01)Article de revue -
Prevalence and correlates of depressive symptoms among undergraduate health science students at the University of Parakou, Benin
(Journal of Epidemiology and Population Health. vol. 72, n° 4, pp. 202525, 2024-05-04)Article de revue -
Optimizing co-prescription of clozapine and antiseizure medications: a systematic review and expert recommendations for clinical practice
(Expert Opinion on Drug Metabolism and Toxicology. vol. 20, n° 5, pp. 347-358, 2024-05-01)Article de revue -
Can We Ask ChatGPT About Drug Safety? Appropriateness of ChatGPT Responses to Questions About Drug Use and Adverse Reactions Received by Pharmacovigilance Centers
(Drug Safety, 2024-05-08)Article de revue